share_log

药明生物拟以5亿美元将爱尔兰疫苗工厂出售给默沙东

WUXI BIO intends to sell its vaccine factory in Ireland to Merck for approximately 0.5 billion US dollars.

Breakings ·  Jan 6 23:58

On the evening of January 6, WUXI BIO announced that its wholly-owned subsidiary WUXI HAIDE plans to sell its vaccine factory in Ireland to Merck, with a total trade value of approximately 0.5 billion dollars.

The translation is provided by third-party software.


The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
    Write a comment